Overview

Study Evaluating Etanercept on Skin and Joint Disease in Psoriatic Arthritis

Status:
Completed
Trial end date:
2008-05-01
Target enrollment:
Participant gender:
Summary
To assess the efficacy of two different treatment regimens of etanercept in psoriasis subjects with psoriatic arthritis with respect to both the skin and joint manifestations.
Phase:
Phase 4
Details
Lead Sponsor:
Wyeth is now a wholly owned subsidiary of Pfizer
Treatments:
Etanercept